Valuation of Common Stock. The Recipient understands that the Company has valued the Shares at $0.12 cents per Share as of the Grant Date, which equals the fair market value of one share of Common Stock as determined by the Company in a manner consistent with Code Section 409A.
Appears in 5 contracts
Samples: Restricted Stock Agreement (Bioadaptives, Inc.), Restricted Stock Agreement (Bioadaptives, Inc.), Restricted Stock Agreement (Bioadaptives, Inc.)
Valuation of Common Stock. The Recipient understands that the Company has valued the Shares at par value, or $0.12 0.0001 cents per Share as of the Grant Date, which equals the fair market value of one share of Common Stock as determined by the Company in a manner consistent with Code Section 409A.
Appears in 2 contracts
Samples: Restricted Stock Agreement (CAT9 Group Inc.), Restricted Stock Agreement (CAT9 Group Inc.)
Valuation of Common Stock. The Recipient understands that the Company has valued the Shares at $0.12 cents 1.11 dollar per Share share as of the Grant Date, which equals the fair market value of one share of Common Stock as determined by the Company in a manner consistent with Code Section 409A.
Appears in 1 contract
Valuation of Common Stock. The Recipient understands that the Company has valued the Shares at $0.12 cents 3.00 per Share share as of the Grant Date, which equals the fair market value of one share of Common Stock common stock as determined by the Company in a manner consistent with Internal Revenue Code Section 409A.409A. Further, the valuation of the Shares at $3.00 per share is equal to the price paid per share by third party investors in the Company’s most recent private placement of common stock.
Appears in 1 contract
